DOC
SLIDES
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Home
›
Search Results for "median cancer"
Search Results for 'median cancer'
median cancer published presentations and documents on DocSlides.
Malawi Cancer Consortium Overview
by min-jolicoeur
Satish Gopal MD MPH. University . of Malawi Colle...
Sipuleucel -T Survival Benefit
by calandra-battersby
Sipuleucel. -T was approved based on HR of 0.775 ...
Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identi
by williams
Foundation Medicine. ctDNA. is good information f...
Complex Cancer Late Effects Rehabilitation Service
by OneAndOnly
(. CCLERS) . Complex Cancer Late Effects Rehabilit...
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
by Soulmate
Andrew J Armstrong MD . ScM. FACP. National Allia...
Significant efforts were made by the Moroccan Ministry of Health as part of the National Cancer Co
by reagan
Patterns of Care (POC) studies are important to . ...
ASCO 2012 Review Gynecologic Cancer
by welnews
Nelson Teng, M.D., Ph.D.. Director, Gynecologic On...
Game Plan Trends in ovarian cancer
by alexa-scheidler
Diagnostic work-up. Treatment. The most commonly ...
Prostate Cancer Screening in 2013: Reports of its Death Are
by min-jolicoeur
Norm D. Smith, M.D.. Associate Professor. Co-Dire...
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
Network Audit 2010
by giovanna-bartolotta
Failure to Obtain Histological / Cytological . Co...
Best of ASCO GU Session Sandy Srinivas.MD
by experimentgoogle
Stanford University. Outline. Abstract #4. :. . I...
Myeloma: Symptoms to diagnosis
by samantha
Can we do better?. [Hospital name]. [Date]. What i...
Surgery for Metastatic Brain Tumor from Breast Cancer
by bella
Tanat Vaniyapong, MD. Neurosurgery Unit, Faculty o...
Median PFS: 2.6 months (95% CI, 1.7-3.5)
by ceila
Median PFS: 1.4 months (95% CI, 1.2-1.6) . Median ...
National data in surgery: LCCOP 2018(2016)
by isla
Doug West Audit Committee Chair, Society for Cardi...
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Grou
by DancingDragonfly
Michael Chuong, M.D.. 1,2. , Smith . Apisarnthanar...
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. UniversitĂ di Napoli Federico II. ...
Andrew H. Ko, MD University of California San Francisco
by test
Gastrointestinal Oncology Program. Treatment of m...
“Critical & Terminal illness – moving to new Frontiers!”
by luanne-stotts
“How long have I got, doc?”. . -not . a ques...
How to describe a graph
by olivia-moreira
Otherwise called. CUSS. 5. In context. You must w...
Metastatic Breast Cancer
by lindy-dunigan
A sub-focus on specific clinical scenarios. What ...
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
Adult granulosa cell tumor
by jamir
associated. with . breast. cancer in Denmark 196...
As it pertains to the last patient in your practice who died of metastatic nonsquamous
by kittie-lecroy
non-small cell lung cancer (NSCLC) . with no targ...
The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016
by phoebe-click
The Impending D eath of Cancer: A Herculean Task...
Immuno-Oncology Dr. Michael Palumbo
by mofferro
April 18, 2018. Immuno-Oncology. Activating the im...
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
by bikersjoker
patients with . advanced breast . cancer and a ger...
Thomas E. Keane Medical University of South Carolina
by valerie
Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...
Results of Phase II study of
by grace3
Durvalumab. in cancer patients with HIV-1 infecti...
Efficacy of sorafenib in patients with
by caitlin
desmoid. -type . fibromatosis. Rodrigo Munhoz. 1. ...
The Impending D eath of Cancer:
by elina
A Herculean Task. Emerging Therapies 2016. Ruemu E...
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
Vanessa A. Lukas 1 , MS4; Tim Craven
by eleanor
2. , . MSPH. ; Ashok K. Hemal. 1. , MD; Ram A. Pa...
nmCRPC ASCO GU 2018 Bobby Shayegan, MD FRCSC
by kylie
Associate Professor & Head. David . Braley. &...
Case Discussion A 52-year-old man initially presented with
by lois-ondreau
nonmuscle. -invasive . bladder cancer. He receive...
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...
Load More...